No significant differences were detected when comparing the other diseases with controls, despite all controls, with the exception of one outlier, presenting HIP1 levels comparable to MSA and much lower than PD, PSP and HD. This evidence concerns the gene HIP1 and supranuclear palsy, progressive, 1.